CN100409877C - Chinese medicine preparation for treating hyperosteogeny - Google Patents
Chinese medicine preparation for treating hyperosteogeny Download PDFInfo
- Publication number
- CN100409877C CN100409877C CNB2005101131805A CN200510113180A CN100409877C CN 100409877 C CN100409877 C CN 100409877C CN B2005101131805 A CNB2005101131805 A CN B2005101131805A CN 200510113180 A CN200510113180 A CN 200510113180A CN 100409877 C CN100409877 C CN 100409877C
- Authority
- CN
- China
- Prior art keywords
- medicine
- hyperosteogeny
- myrrha
- olibanum
- angelicae sinensis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a new external-use medicine for treating cervical vertebra hyperplasia, lumbar vertebra hyperplasia, lumbar disc protrusion, etc. The medicine is prepared from 13 Chinese herbal medicines as raw materials such as camphor, etc. According to different properties of a plurality of Chinese medicines, the medicines are prepared into the medicine after respectively being pretreated by being stir-baked in a cast iron pan and stir-baked with vinegar. The medicine has the advantages of scientific and unique formula and outstanding curative effect.
Description
Technical field
The present invention relates to a kind of main treatment with hyperosteogeny, hyperosteogeny, prolapse of lumbar intervertebral disc, scapulohumeral periarthritis etc. is main external used medicine.Be to be the medicament of feedstock production with the Chinese herbal medicine specifically.
Background technology
Motherland's medical science has such theory to cervical spondylosis, scapulohumeral periarthritis etc.: pain is then obstructed, and general rule is not bitterly.Nothing is cold painless, and the pain happiness was sent out in winter, two seasons of spring.Wind, cold, wet, evil four gas are assorted forms numbness to closing.Its therapeutic scheme mainly be dispel the wind, dehumidifying, cold relieving, and prescription is oral medicine mostly, medicine for external use also is no lack of its minority recently.
The external used medicine of state's internal therapy cervical vertebra, hyperosteogeny, scapulohumeral periarthritis is numerous at present, chooses two kinds of popular ointment now to as directed.One: " DONGFANG HUOXUE GAO " that east, Jinan pharmaceutical factory produces, (the accurate word Z37020953 of traditional Chinese medicines) waits 27 Chinese prescriptions of distinguishing the flavor of to form with " Radix Aconiti, Radix Aconiti Kusnezoffii, Flos Carthami, Rhizoma Et Radix Notopterygii, Scorpio ", its " function cure mainly into, expelling wind and cold, relaxing muscles and tendons and activating QI and blood in the collateral; Be used for shoulder arm lumbago and skelalgia, numb limbs and tense tendons due to the anemofrigid-damp arthralgia ".Its two: " dog skin plaster " that Beijing joint-stock company of Tongrentang produces, (the accurate word Z11020207 of traditional Chinese medicines) wait 26 Chinese prescriptions of distinguishing the flavor of to form with " Radix Aconiti, Radix Angelicae Pubescentis, Fructus Chaenomelis, Oleum Terebinthinae, Borneolum Syntheticum ", " function cures mainly and is expelling wind and cold, promoting blood circulation and stopping pain for it.Be used for wind-cold damp pathogen, traumatic injury, gather mass in the abdomen." major defect of its existence is: for hyperosteogeny, hyperosteogeny, diseases such as prolapse of lumbar intervertebral disc, it is slow to take effect, (just can take effect about two weeks sometimes), efficiency time is not long, easily recurs.Both incur loss through delay conditions of patients, increased financial burden again.Can accept a kind of medical product but still be no lack of for the Most patients masses.
Summary of the invention
The object of the present invention is to provide a kind of pure Chinese medicine topical agent, it is for hyperosteogeny, hyperosteogeny, prolapse of lumbar intervertebral disc, and scapulohumeral periarthritis etc. provide a kind of convenience, topical agent effective, without any side effects.This medicament called after skeletal slaking powder.
It is relevant theoretical based on motherland's medical science that technical solution of the present invention is the inventor, thinks that disease exopathogenic factor such as hyperosteogeny has relation with affection of exogenous wind-cold, damp, and modal and trauma history has relation, endogenous cause of ill and kidney, liver two void, and deficient qi and blood has relation.So Therapeutic Principle of the present invention is: drive that stagnation resolvation is swollen, hard masses softening and resolving, promoting blood circulation and stopping pain.Feature at diseases such as hyperosteogeny, waist neck hypertrophy, relevant theoretical in conjunction with motherland's medical science, drawn blood stasis removing in motherland's medicine selectively, invigorated blood circulation, the prescription elite of collateral dredging, sum up clinical experience for many years, filter out scientifically prescription of Chinese herbal medicine evident in efficacy, develop the medicine for external use skeletal slaking powder of diseases such as specially controlling hyperosteogeny, hyperosteogeny, prolapse of lumbar intervertebral disc, scapulohumeral periarthritis.It is treated targetedly for hyperosteogeny, hyperosteogeny, prolapse of lumbar intervertebral disc, scapulohumeral periarthritis etc., reaches ideal curative effect.
Skeletal slaking powder of the present invention is made (consumption is a weight portion) by the following traditional Chinese medicines component
Camphora 2.5～3.5 Sanguis Draxonis 1.5～2.5 Radix Notoginsengs 1.5～2.5
Olibanum 0.5～1.5 Myrrha 0.5～1.5 Flos Carthami 0.1～0.6
Rhizoma Drynariae 0.5～1.5 beautiful osmanthus 0.1～0.6 Pollen Typhae 0.5～1.5
Rhizoma Chuanxiong 0.5～1.5 Radix Angelicae Sinensis 0.5～1.5 Eupolyphaga Seu Steleophaga 1.5～2.5
Lignum Dalbergiae Odoriferae 0.5～1.5
Skeletal slaking powder optimum weight of the present invention (part) proportioning is:
Camphora 3 Sanguis Draxonis 2 Radix Notoginsengs 2 Eupolyphaga Seu Steleophagas 2
Olibanum 1 Myrrha 1 Flos Carthami 0.5 Rhizoma Drynariae 1
Beautiful osmanthus 0.5 Pollen Typhae, 1 Rhizoma Chuanxiong, 1 Radix Angelicae Sinensis 1
Lignum Dalbergiae Odoriferae 1
The preparation method of making skeletal slaking powder of the present invention by above-mentioned each component is:
1, fries Olibanum, Myrrha with cast iron pan earlier;
2, back vinegar Radix Angelicae Sinensis (parched), Rhizoma Chuanxiong;
3,, preserve with vial or porcelain vase again the pulverization of putting together of other Chinese herbal medicine in the prescription;
When 4, the patient uses, add market general Dieda plaster for curing traumatic injury on sale and mix well use.
Skeletal slaking powder of the present invention has the following advantages:
Skeletal slaking powder is made up of traditional secret recipe prescriptions such as " Cortex torricelliae tiliifoliaes ", has that the stagnation resolvation of driving is swollen, an effect of dredge the meridian passage, hard masses softening and resolving, promoting blood circulation and stopping pain.Because it is a medicine for external use,, significant curative effect is arranged for diseases such as hyperosteogeny, hyperosteogeny, prolapse of lumbar intervertebral disc, scapulohumeral periarthritis so dosage prescription relatively more for oral administration wants big 1-2 doubly, have instant effect: 1.5～4.8 hours take effect, that is: pain disease is eliminated, and other various symptoms are alleviated thereupon; Relapse rate is low, and general being difficult for recurs, even indivedual recurrence, its symptom before alleviates, and many cases on probation, does not see the case that any toxic and side effects reaction is arranged.Easy to use, an adhesive plaster can stick the affected part in the patient at any time, everywhere; If massage treatment next day of auxilliary again, curative effect is more obvious.
The skeletal slaking powder medical effect sees following table for details
| Title | The example number | Cure number | Significant figure | Invalid number | Effective percentage % |
| Hyperosteogeny | 50 | 50 | 50 | 0 | 100 |
| Hyperosteogeny | 20 | 18 | 19 | 1 | 95 |
| Prolapse of lumbar intervertebral disc | 90 | 80 | 82 | 8 | 90 |
| Scapulohumeral periarthritis | 10 | 9 | 1 | 90 |
The specific embodiment
Embodiment.Executing of pain disease such as hyperosteogeny, hyperosteogeny, prolapse of lumbar intervertebral disc, scapulohumeral periarthritis are controlled.
1, the composition of medicine and proportioning
Camphora 3g Sanguis Draxonis 2g Radix Notoginseng 2g
Eupolyphaga Seu Steleophaga 2g Olibanum 1g Myrrha 1g
The beautiful osmanthus 0.5g of Flos Carthami 0.5g Rhizoma Drynariae 1g
Pollen Typhae 1g Rhizoma Chuanxiong 1g Radix Angelicae Sinensis 1g
Lignum Dalbergiae Odoriferae 1g
2, preparation method and use
Earlier with cast iron pan parch Olibanum, Myrrha, the back is with vinegar Radix Angelicae Sinensis (parched), Rhizoma Chuanxiong, the pulverization of putting together of other Chinese herbal medicine in the prescription, adorns in the pouch, and preserves with vial or porcelain vase then.Its using method is: spread out with the Dieda plaster for curing traumatic injury that sell in market, add this medicamental pulverata, the softening use of mixing well of heating; One plaster (available 3-5 days) is a course of treatment, general 3-5 course of treatment.
Claims (2)
1. medicine for external use for the treatment of hyperosteogeny, hyperosteogeny, prolapse of lumbar intervertebral disc, scapulohumeral periarthritis disease is characterized in that it is made by following weight proportioning crude drug, and cooperates commercially available Dieda plaster for curing traumatic injury to use:
Camphora 2.5-3.5 Sanguis Draxonis 1.5-2.5 Radix Notoginseng 1.5-2.5
Olibanum 0.5-1.5 Myrrha 0.5-1.5 Flos Carthami 0.1-0.6
The beautiful osmanthus 0.1-0.6 Pollen Typhae 0.5-1.5 of Rhizoma Drynariae 0.5-1.5
Rhizoma Chuanxiong 0.5-1.5 Radix Angelicae Sinensis 0.5-1.5 Lignum Dalbergiae Odoriferae 0.5-1.5
Eupolyphaga Seu Steleophaga 1.5-2.5.
2. medicine for external use according to claim 1, wherein each crude drug weight proportion is:
Camphora 3g Sanguis Draxonis 2g Radix Notoginseng 2g Eupolyphaga Seu Steleophaga 2g
Olibanum 1g Myrrha 1g Flos Carthami 0.5g Rhizoma Drynariae 1g
Beautiful osmanthus 0.5g Pollen Typhae 1g Rhizoma Chuanxiong 1g Radix Angelicae Sinensis 1g
Lignum Dalbergiae Odoriferae 1g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005101131805A CN100409877C (en) | 2005-10-16 | 2005-10-16 | Chinese medicine preparation for treating hyperosteogeny |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005101131805A CN100409877C (en) | 2005-10-16 | 2005-10-16 | Chinese medicine preparation for treating hyperosteogeny |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1857544A CN1857544A (en) | 2006-11-08 |
| CN100409877C true CN100409877C (en) | 2008-08-13 |
Family
ID=37296532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005101131805A Expired - Fee Related CN100409877C (en) | 2005-10-16 | 2005-10-16 | Chinese medicine preparation for treating hyperosteogeny |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100409877C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104095973A (en) * | 2014-07-30 | 2014-10-15 | 吴英娥 | Externally-used traditional Chinese medicine composition for treating hyperostosis and preparation of externally-used traditional Chinese medicine composition |
| CN104324136A (en) * | 2014-11-14 | 2015-02-04 | 马朝栋 | Traditional Chinese medicine unguent for treating osteoproliferation and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1059096C (en) * | 1996-01-05 | 2000-12-06 | 李振 | Method of preparing medicated wine for treating injury and setting bone |
-
2005
- 2005-10-16 CN CNB2005101131805A patent/CN100409877C/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1059096C (en) * | 1996-01-05 | 2000-12-06 | 李振 | Method of preparing medicated wine for treating injury and setting bone |
Non-Patent Citations (6)
| Title |
|---|
| 中华人民共和国药典2000年版一部. 国家药典委员会，396，化学工业出版社. 2000 |
| 中华人民共和国药典2000年版一部. 国家药典委员会，396，化学工业出版社. 2000 * |
| 辨证治疗骨质增生症128例疗效观察. 刘维庆.山西中医，第19卷第4期. 2003 |
| 辨证治疗骨质增生症128例疗效观察. 刘维庆.山西中医，第19卷第4期. 2003 * |
| 骨质增生的治疗近况. 孙玉凤，刘桂缺等.河北中医药学报，第13卷第4期. 1998 |
| 骨质增生的治疗近况. 孙玉凤，刘桂缺等.河北中医药学报，第13卷第4期. 1998 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1857544A (en) | 2006-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102178735A (en) | Blood circulation promoting, vein relaxing and obstruction eliminating pills and preparation process thereof | |
| CN106214752A (en) | One treats traumatic injury, fracture Chinese medicine composition and preparation method thereof | |
| CN102895365B (en) | External ointment for treating bone injury and orthopedics inflammation | |
| CN102008610A (en) | Traditional Chinese medicine composition for curing hyperosteogeny | |
| CN102357164A (en) | Medicine composition for clinical care of burns and preparation method thereof | |
| CN100409877C (en) | Chinese medicine preparation for treating hyperosteogeny | |
| CN101884687B (en) | Specific medicament for treating empyrosis and preparation method thereof | |
| CN108498617A (en) | Rheumatalgia Chinese medicine composition and its preparation method and application, lavipeditum packet and preparation method thereof and pharmaceutical preparation | |
| CN101554449B (en) | Traditional Chinese medicine for traumatic curing | |
| CN103230535A (en) | Medicinal liquor with function of activating collaterals to ease pain | |
| CN103040940A (en) | Traditional Chinese medicine composition for treating common cold due to wind-cold | |
| CN102727773B (en) | Traditional Chinese medicinal capsule for treating blood mucoviscidosis | |
| CN101934016B (en) | External medicament for treating arthritis | |
| CN1839974B (en) | Medicine composition for treating rheumatoid disease and method for preparing the same | |
| CN101264305B (en) | Medicaments for treating no fever type common cold | |
| CN102343081A (en) | Moxibustion tool of pure Chinese medicinal preparation for treating bone aching and pure Chinese medicinal preparation for treating bone aching | |
| CN103736053B (en) | A kind of Tong,-a that treats pain in waist and lower extremities, protrusion of lumber intervertebral disc treats medicine | |
| CN102716381A (en) | Traditional Chinese medicine used for treating appendicitis | |
| CN102784272A (en) | Traditional Chinese medicine application agent for preventing and treating tonsils and throat inflammation induced by respiratory tract infection, and preparation method thereof | |
| CN103055101B (en) | Chinese medicine for treating lumbar spondylosis | |
| CN103055246A (en) | Bone impediment pain-eliminating pill | |
| CN106361840A (en) | Traditional Chinese medicine composite used for treating rheumatism and preparing method thereof | |
| CN101983712A (en) | Novel medicament for treating coronary heart disease | |
| CN101843886A (en) | Medicine containing saussurea and for curing rheumatic bone disease and preparation method thereof | |
| CN103893436A (en) | Externally applied medicine for treatment of rheumatism |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080813 Termination date: 20091116 |